Skip to main content

Phibro Animal Health Corp

PAHC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001069899

No open-market purchases or sales by Phibro Animal Health Corp insiders were filed in the last 90 days; 208 institutions reported holding it in 13F filings for Q2 2026, worth $660.4M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Phibro Animal Health Corp changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of PAHC: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders131125−6
Shares20.3M20.1M−199.9K (−1.0%)
Value$273.7M$257.1M−$16.6M (−6.1%)

New holders (12)

Institutions that held Phibro Animal Health Corp at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to PAHC in Q3 2023
InstitutionSharesValue% of portfolio
Marshall Wace, LLP34,235$437.2K0.00%
Voya Investment Management LLC17,947$229.2K0.00%
Madison Wealth Management15,987$204.2K0.04%
Jump Financial, LLC15,500$197.9K0.01%
Illinois Municipal Retirement Fund12,668$162.0K0.00%
Cubist Systematic Strategies, LLC12,246$156.4K0.00%
SG Americas Securities, LLC9,867$126.0K0.00%
Qube Research & Technologies Ltd2,673$34.1K0.00%
Aquatic Capital Management LLC1,600$20.0K0.00%
Vestcor Inc1,515$19.0K0.00%
Point72 Asset Management, L.P.66$8370.00%
Global Retirement Partners, LLC10$1260.00%

Sold out (18)

Institutions that held Phibro Animal Health Corp at the end of Q2 2023 and filed for Q3 2023 without it.